Company Information
CIN
Status
Date of Incorporation
28 November 2005
State / ROC
Delhi / ROC Delhi
Last Balance Sheet
31 March 2023
Last Annual Meeting
06 July 2023
Paid Up Capital
234,538,830
Authorised Capital
335,000,000
Directors
Nupur Mehrotra
Director/Designated Partner
over 2 years ago
over 2 years ago
Prabuddha Kumar Kundu
Director/Designated Partner
over 2 years ago
over 2 years ago
Saumen Chakraborty
Director/Designated Partner
over 3 years ago
over 3 years ago
Debjit Patra
Director
about 12 years ago
about 12 years ago
Goutam Das
Director/Designated Partner
about 13 years ago
about 13 years ago
Avijit Das
Director/Designated Partner
almost 20 years ago
almost 20 years ago
Past Directors
Praveen Kumar Gupta
Director
about 13 years ago
about 13 years ago
Priyanka Manghwani
Company Secretary
over 15 years ago
over 15 years ago
Narahari Kousik
Additional Director
about 17 years ago
about 17 years ago
John Ernest Siddall
Director
almost 20 years ago
almost 20 years ago
Peter John Lennox
Director
almost 20 years ago
almost 20 years ago
Patents
"METHOD FOR DETECTION OF HEPATITIS NUCLEIC ACID AND
USES THEREOF" ABSTRACT
The present invention relates to a method for detection, enumeration and/or identification of a disease related condition where the disease is caused by an infectious agent selected from a group consisting of Hepatitis A virus. Hepatitis B ...
"NUCLEIC ACID BASED DETECI ION METHODS"
A process, sets of oligonucleotides and kits lor detecting disease and non-disease related conditions inclusive of but not limited to infections. drug resistance, mutations, genetic diseases, cancer and/or SNP variations in a sample are provided herein.
The present invention provides modified polynucleotide sequences coding for human cytochrome P450 reductase, human cytochrome P450 and human cytochrome b5. Further a genetically modified protease deficient yeast strain comprising integrated modified human cytochrome P450 reductase gene is provided in the present inv...
The present invention provides modified polynucleotide sequences coding for human cytochrome P450 reductase, human cytochrome P450 and human cytochrome b5. Further a genetically modified protease deficient yeast strain comprising integrated modified human cytochrome P450 reductase gene is provided in the present inv...
The present invention discloses a device and method for multidimensional cell culture, a more particularly
three-dimension (3D) and four-dimension (4D) device and method. The device and method of the present
invention comprises growing cells as spheroids/tissueoids on non-woven fabric scaffold to create 3D tissuel...
The present invention provides a versatile yeast-based recombinant expression platform for the
enhanced expression of full length or truncated target “Difficult to Express” proteins (DTE-Ps) of
diverse origin and families. Constructs, methods and kits involved in expressing such DTE-Ps
through the said system are...
The present invention relates to expression of SARS-CoV like virus proteins [S, M and E] proteins; recombinant polynucleotides, polypeptides; constructs, virus-like particles (VLPs); immunogenic compositions or vaccines comprising Virus Like Particles (VLPs). Method of producing the VLPs/ expressing the multi-subuni...
The present invention relates to expression of SARS-CoV like virus proteins [S, M and E]
proteins; recombinant polynucleotides, polypeptides; constructs, virus-like particles (VLPs);
immunogenic compositions or vaccines comprising Virus Like Particles (VLPs). Method of
producing the VLPs/ expressing the multi-sub...
The present invention provides a versatile recombinant expression platform for expression of multi-antigen VLPs and VLP-RNA complexes particularly, VLP-mRNA complexes. The present invention provides a VLP-mRNA complex encapsulating mRNA inside VLP with increased thermostability and protection from ribonucleases, hen...
Registered Trademarks
[Class : 5] Pharmaceutical, Veterinary And Sanitary Preparations; Dietetic Substances Adapted For Medical Use, Food For Babies; Plasters, Materials For Dressings; Materials For Stopping Teeth, Dental Wax; Disinfectants; Preparation For Destroying Vermin; Fungicides, Herbicides And Protein Production, Process Development, Protocol Development Scale Up Studies, Vaccines, Medic...
[Class : 5] Pharmaceutical, Veterinary And Sanitary Preparations; Dietetic Substances Adapted For Medical Use, Food For Babies; Plasters, Materials For Dressings; Materials For Stopping Teeth, Dental Wax; Disinfectants; Preparation For Destroying Vermin; Fungicides, Herbicides.[Class : 9] Scientific, Nautical, Surveying, Electric, Photographic, Cinematographic, Optical, Weig...
[Class : 5] Pharmaceutical, Veterinary And Sanitary Preparations; Dietetic Substances Adapted For Medical Use, Food For Babies; Plasters, Materials For Dressings; Materials For Stopping Teeth, Dental Wax; Disinfectants; Preparation For Destroying Vermin; Fungicides, Herbicides.[Class : 44] Medical Services, Veterinary Services, Hygienic And Beauty Care For Human Beings Or An...
View +8 more Brands for Premas Biotech Private Limited.
Charges
05 July 2013
Canara Bank
1 Crore
16 September 2022
The Hongkong And Shanghai Banking Corporation Limited
0
11 March 2022
Hdfc Bank Limited
0
05 July 2013
Canara Bank
0
07 September 2021
Hdfc Bank Limited
0
16 September 2022
The Hongkong And Shanghai Banking Corporation Limited
0
11 March 2022
Hdfc Bank Limited
0
05 July 2013
Canara Bank
0
07 September 2021
Hdfc Bank Limited
0
16 September 2022
The Hongkong And Shanghai Banking Corporation Limited
0
11 March 2022
Hdfc Bank Limited
0
05 July 2013
Canara Bank
0
07 September 2021
Hdfc Bank Limited
0
Documents
Form DPT-3-24122020-signed
Form MGT-7-02012020_signed
List of share holders, debenture holders;-26122019
Copy of MGT-8-26122019
Form AOC-4(XBRL)-08112019_signed
XBRL financial statements duly authenticated as per section 134 (including Board's report,auditor's report and other documents)-01112019
Form DIR-12-19112018_signed
Evidence of cessation;-19112018
Optional Attachment-(1)-19112018
Form MGT-7-27092018_signed
List of share holders, debenture holders;-14092018
Copy of MGT-8-14092018
Optional Attachment-(1)-14092018
Form AOC-4(XBRL)-22082018_signed
XBRL financial statements duly authenticated as per section 134 (including Board's report,auditor's report and other documents)-16082018
Form MGT-14-14082018_signed
Optional Attachment-(1)-14082018
Copy(s) of resolution(s) along with copy of explanatory statement under section 173-14082018
Declaration of the appointee director, Managing director, in Form No. DIR-2;-14082018
Optional Attachment-(1)-14082018
Form DIR-12-14082018_signed
Form ADT-1-01082018_signed
Copy of written consent given by auditor-01082018
Copy of the intimation sent by company-01082018
Copy of resolution passed by the company-01082018
Optional Attachment-(3)-16022018
Form DIR-12-16022018_signed
Optional Attachment-(2)-16022018
Declaration of the appointee director, Managing director, in Form No. DIR-2;-16022018
Optional Attachment-(1)-16022018
